CD8A and lymphoma: These in vitro data were further supported by in vivo observations that adoptive transfer of CD8+ T cells isolated from Lpar5−/− mice were more effective at reducing the growth rate of both EG7 lymphoma and B16F10 melanoma tumors compared to wild type CD8+ T cells [43,116].